Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - PLUS THERAPEUTICS, INC. | Financial_Report.xls |
| EX-31.1 - EXHIBIT 31.1 - PLUS THERAPEUTICS, INC. | ex31_1.htm |
| EX-3.1 - EXHIBIT 3.1 - PLUS THERAPEUTICS, INC. | ex3_1.htm |
| EX-23.1 - EXHIBIT 23.1 - PLUS THERAPEUTICS, INC. | ex23_1.htm |
| EX-31.2 - EXHIBIT 31.2 - PLUS THERAPEUTICS, INC. | ex31_2.htm |
| 10-K - CYTORI THERAPEUTICS, INC 10-K 12-31-2014 - PLUS THERAPEUTICS, INC. | form10k.htm |
EXHIBIT 32.1
CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350/ SECURITIES EXCHANGE ACT RULE 13a-14(b), AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES – OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Cytori Therapeutics, Inc. for the year ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof Marc H. Hedrick, as President & Chief Executive Officer of Cytori Therapeutics, Inc., and Tiago Girão, as VP of Finance and Chief Financial Officer of Cytori Therapeutics, Inc., each hereby certifies, respectively, that:
| 1. | The Form 10-K report of Cytori Therapeutics, Inc. that this certification accompanies fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934. |
| 2. | The information contained in the Form 10-K report of Cytori Therapeutics, Inc. that this certification accompanies fairly presents, in all material respects, the financial condition and results of operations of Cytori Therapeutics, Inc. |
|
By:
|
/s/ Marc H. Hedrick, MD
|
|
|
Dated: March 16, 2015
|
Marc H. Hedrick, MD
|
|
|
President & Chief Executive Officer
|
||
|
By:
|
/s/ Tiago M. Girão
|
|
|
Dated: March 16, 2015
|
Tiago M. Girão
|
|
|
VP of Finance and Chief Financial Officer
|